Han Chu Lee

机构：Ulsan College, Asan Medical Center, University of Ulsan · ORCID：0000-0002-7631-4124

发表论文 422 篇 · 总被引 16404 次 · h-index 64

代表论文

Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 24)
GS-007 Abbreviated gadoxetic acid–enhanced magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance in high-risk patients: a randomized controlled trial (2026 · Journal of Hepatology · 被引 1)
Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data (2026 · Clinical Cancer Research · 被引 1)
Transarterial Chemoembolization Alone Versus Combined With Radiation Therapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 1)
Abbreviated gadoxetic acid–enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol (2025 · Hepatology Communications · 被引 1)
Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study (2025 · Journal of Hepatocellular Carcinoma · 被引 1)